Omixon Biocomputing, Budapest, Hungary.
PLoS One. 2013 Nov 6;8(11):e78410. doi: 10.1371/journal.pone.0078410. eCollection 2013.
Specific HLA genotypes are known to be linked to either resistance or susceptibility to certain diseases or sensitivity to certain drugs. In addition, high accuracy HLA typing is crucial for organ and bone marrow transplantation. The most widespread high resolution HLA typing method used to date is Sanger sequencing based typing (SBT), and next generation sequencing (NGS) based HLA typing is just starting to be adopted as a higher throughput, lower cost alternative. By HLA typing the HapMap subset of the public 1000 Genomes paired Illumina data, we demonstrate that HLA-A, B and C typing is possible from exome sequencing samples with higher than 90% accuracy. The older 1000 Genomes whole genome sequencing read sets are less reliable and generally unsuitable for the purpose of HLA typing. We also propose using coverage % (the extent of exons covered) as a quality check (QC) measure to increase reliability.
特定的 HLA 基因型与某些疾病的抵抗力或易感性或对某些药物的敏感性有关。此外,HLA 高精度分型对于器官和骨髓移植至关重要。迄今为止,最广泛使用的高分辨率 HLA 分型方法是基于 Sanger 测序的分型(SBT),而基于下一代测序(NGS)的 HLA 分型刚刚开始被采用作为一种更高通量、更低成本的替代方法。通过对公共 1000 基因组配对 Illumina 数据中的 HapMap 子集进行 HLA 分型,我们证明了从外显子组测序样本中以高于 90%的准确率进行 HLA-A、B 和 C 分型是可能的。较旧的 1000 基因组全基因组测序读取集不太可靠,通常不适合 HLA 分型目的。我们还建议使用覆盖率%(覆盖的外显子的程度)作为质量检查(QC)措施来提高可靠性。